Breaking News

Financial Report: Charles River Labs

February 10, 2016

Manufacturing Support segment drives growth in the quarter

Charles River Labs
 
4Q Revenues: $353.9 million (+7%)

4Q Earnings: $32.4 million (+17%)

FY Revenues: $1.4 billion (+5%)

FY Earnings: $151.1 million (+18%)

Comments: Revenue for the Research Models and Services segment was $114.7 million in the quarter, down 3%. Discovery and Safety Assessment revenues were $160.5 million, up 7%. Manufacturing Support revenues were $78.6 million, up 26%, reflecting the acquisitions of Celsis and Sunrise Farms, which contributed 14% to revenue growth. Foreign exchange reduced reported revenue growth by 4%.
  • Analytical Testing Outsourcing Trends Update

    Analytical Testing Outsourcing Trends Update

    January 26, 2017
    Spurred by many factors, global analytical testing services market is experiencing rapid growth in the range of 11% per year

  • CROs and Today’s  R&D Landscape

    CROs and Today’s R&D Landscape

    Kristin Brooks, Associate Editor, Contract Pharma||November 9, 2016
    John Lewis of ACRO discusses opportunities, challenges, and the future CRO

  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus